Global genetic sequencing firm Eone Diagnomics Genome Center (EDGC) will provide home healthcare services to Seoul's Seongdong District's workers and their families.

The Incheon-based company signed the agreement with the district office, Seongdong City Management Corporation and the Seongdong Foundation for Arts and Culture on Oct. 13. The company will provide diagnostic test kits that can be used at home to take samples for analysis. The person can then check the results online.

It is the firm's first such signing with a Seoul district government.

EDGC told The Korea Times that the company's genetic sequencing technologies will promote "preemptive health management standards" and be "an exemplary case of managing employees' health status."

The company also aims to publicly promote its personalized healthcare service based on predictive diagnosis of diseases like cancer using high-end genetic big-data algorithms.

Seongdong District Office head Chong Won-o expressed hope that "EDGC's genetic sequencing services that can trace back one's family history for disease background can open up ways for health management for the office workers and their family members and hopefully district residents as well later."

EDGC said the company will develop a program to allow the district office to manage the health status of its residents.

Alongside American firm GRAIL, EDGC leads the global genetic sequencing industry with a liquid biopsy that allows predictive diagnosis of diseases using cell-free DNA analyses.

EDGC launched NICE, a non-invasive prenatal test based on cell-free DNA analyses that won recognition from the Ministry of Trade and Industry in November 2019. The company recently issued convertible bonds for the first time in the country's bio-industry history.